S
Sage Therapeutics (SAGE)
$000.00 0.00% ($0.00)
- Today
- Week
- Month
- Year
- 5 Year
- YTD
getbaraka.com
About Sage Therapeutics (SAGE)
SAGE Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company is engaged in developing and commercializing medicines to treat central nervous system (CNS) disorders. The Company's lead product candidate, SAGE-547 is an intravenou... Read more
- USD9.15
- USD9.20
- USD9.11
- USD13.47
- 40.90%
- 47M
- 2.22M
- 576M
- 4.62
- -13.40%
Stock News
4 hours ago
Liberty Energy Inc. Announces Date Change for its Second Quarter 2025 Earnings Release and Conference Call
Yahoo
yesterday
Jim Cramer says Trump's latest round of tariffs isn't 'meaningful'
CNBC
yesterday
Pro golfer Bryson Dechambeau says anyone outside the top 165 on the PGA Tour ‘is losing money’
MarketWatch
yesterday
CoreWeave to acquire Core Scientific in $9 billion all-stock deal
CNBC
Unlock More Stock Analysis & Reports
Access detailed stock analysis from LSEG including analyst price target estimates.
